编辑精选——颈动脉内膜剥脱术或颈动脉支架置入术后卒中与死亡:法国十年全国性研究
这项回顾性全国队列研究利用法国PMSI医院数据库,纳入2010至2019年接受颈动脉内膜剥脱术(CEA)或颈动脉支架置入术(CAS)的患者,比较术后30天内围手术期卒中或死亡(PPSD30)风险。匹配调整后,CAS组PPSD30风险显著高于CEA组,症状性患者中差异更明显,作者认为许多接受CAS等操作的患者可能受害大于获益。
要点
- 2010至2019年法国共164248例颈动脉手术,其中CEA 156561例、CAS 7687例。
- 总体PPSD30率为1.5%,CEA后1.5% vs CAS后2.4%。
- 匹配调整后CAS组PPSD30风险显著高于CEA组(总体aOR 1.4,95%CI 1.1-1.8)。
核心结论
- 这项全国性真实世界研究显示CEA表现优于CAS,在症状性患者中更明显,在无症状患者中亦然。
- 作者指出,许多患者接受的操作(即所有无症状女性、所有高手术风险患者以及所有接受CAS者)根据既往随机试验结论可能受害大于获益。
研究设计与样本
- 回顾性全国队列研究,使用法国PMSI医院数据库。
- 纳入2010至2019年在法国接受CEA或CAS的所有患者,共164248例:CEA 156561例,CAS 7687例(包括约25%无症状女性和40%高手术风险患者)。
- 采用随机效应逻辑回归模型比较CEA或CAS后PPSD30的发生,并通过倾向性评分匹配考虑高手术风险,并调整患者和医院特征。
- 分析按症状性和无症状患者分别分层。
主要发现
- 总体PPSD30率为1.5%(n=2514例患者):CEA后1.5% vs CAS后2.4%。
- 无症状患者PPSD30率为1.3%:CEA后1.2% vs CAS后1.8%。
- 症状性患者PPSD30率为3.3%:CEA后3.1% vs CAS后6.5%。
- 匹配调整后,CAS组PPSD30风险显著高于CEA组:总体aOR 1.4(95%CI 1.1-1.8);无症状患者aOR 1.4(95%CI 1.1-1.8);症状性患者aOR 2.7(95%CI 1.8-4.0)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This retrospective, nationwide cohort study aimed to compare peri-procedural stroke or death within 30 days of the procedure (PPSD30) in patients who underwent carotid endarterectomy (CEA) or carotid stenting (CAS). METHODS: This retrospective cohort study used data from the French hospital database PMSI. All patients who underwent CEA or CAS between 2010 and 2019 in France were included. Information on individual patients and hospital characteristics was retrieved. A random effects logistic regression model compared the occurrence of PPSD30 after CEA or CAS. High surgical risk was accounted for by using propensity score matching and adjusted for patient and hospital characteristics. Analyses were also stratified to consider symptomatic and asymptomatic patients separately. RESULTS: Between 2010 and 2019, 164 248 patients underwent a carotid artery procedure in France: 156 561 CEA and 7 687 CAS (including about 25% asymptomatic women and 40% high risk patients). The PPSD30 rate was 1.5% overall (n = 2 514 patients) (1.5% after CEA vs. 2.4% after CAS), 1.3% in asymptomatic patients (1.2% after CEA vs. 1.8% after CAS), and 3.3% in symptomatic patients (3.1% after CEA vs. 6.5% after CAS). After matching and adjustment, the risk of PPSD30 was statistically significantly greater in patients who underwent CAS than in patients who underwent CEA (adjusted OR [aOR] 1.4, 95% confidence interval [CI] 1.1 - 1.8 overall; aOR 1.4, 95% CI 1.1 - 1.8 in asymptomatic patients; and aOR 2.7, 95% CI 1.8 - 4.0 in symptomatic patients). CONCLUSION: This nationwide real life study showed that CEA performed better than CAS, more markedly in symptomatic patients, but also in asymptomatic patients. Moreover, many patients received procedures that were more likely to be harmful than beneficial according to conclusions from past randomised trials (i.e., all asymptomatic women, all high surgical risk patients, and all who had undergone CAS).
引用
- Steinmetz E, Cottenet J, Mariet AS, et al. Editor's Choice - Stroke and Death Following Carotid Endarterectomy or Carotid Artery Stenting: A Ten Year Nationwide Study in France. Eur J Vasc Endovasc Surg. 2024. PMID: 39490630. doi:10.1016/j.ejvs.2024.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。